Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Comparison between the European SCORE and the updated SCORE2 for Cardiovascular outcomes
Session:
Posters (Sessão 1 - Écran 6) - DAC e Cuidados Intensivos 1 - Síndromes Coronários Crónicos
Speaker:
Margarida Temtem
Congress:
CPC 2022
Topic:
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
Theme:
12. Coronary Artery Disease (Chronic)
Subtheme:
12.5 Coronary Artery Disease – Prevention
Session Type:
Pósters Electrónicos
FP Number:
---
Authors:
Margarida Temtem; Maria Isabel Mendonça; Marco Serrão; Marina Santos; Débora sá; Carolina Soares; Ana Célia Sousa; Mariana Rodrigues; Sonia Freitas; Eva Henriques; Sofia Borges; Ilídio Ornelas; António Drumond; Roberto Palma Dos Reis
Abstract
<p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong><span style="background-color:white"><span style="color:black">Background: </span></span></strong><span style="background-color:white"><span style="color:black">The European Systematic Coronary Risk Evaluation (SCORE) has predicted a </span></span><span style="background-color:white"><span style="color:black">10-year risk of Cardiovascular Disease (CVD) since 1986. It included </span></span><span style="color:black">only fatal CVD outcomes, underestimating the total CVD burden, especially for younger people. To counteract this issue, a new SCORE was created (</span><span style="background-color:white"><span style="color:black">SCORE2)</span></span><span style="color:black"> to estimate 10-year fatal and non-fatal CVD risk in Europeans without previous CVD or diabetes aged 40–69 years.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong><span style="background-color:white"><span style="color:black">Purpose</span></span></strong><span style="background-color:white"><span style="color:black">: Establish a comparison between SCORE and SCORE2 in terms of CV outcomes for a moderate-risk population.</span></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong><span style="background-color:white"><span style="color:black">Methods: </span></span></strong><span style="background-color:white"><span style="color:black">A population of 1,178 individuals without CVD was stratified by three risk categories for SCORE and SCORE2: low, moderate and high risk. Using t-test and Chi-square, we compared the two scores in terms of means and risk categories. Kaplan-Meier estimator evaluated MACE occurrence for each category of the two scores during an extended follow-up (</span></span><span style="color:black">mean of 5.2±3.4 years). MACE discriminative capacity of SCORE and SCORE2 was verified through C-index methodology.</span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong><span style="background-color:white"><span style="color:black">Results: </span></span></strong><span style="background-color:white"><span style="color:black">The means of the two scores were significantly different (p<0.0001): 2.1±2.4 for SCORE and 6.0±3.3 for SCORE2. One hundred individuals at the lowest risk category of SCORE moved to the highest category of SCORE2. SCORE2 showed a better discrimination capacity for MACE (C-index 0.678) relatively to SCORE (C-index 0.591), with statistical significance (p<0.0001).</span></span></span></span></p> <p style="text-align:justify"><span style="font-size:11pt"><span style="font-family:Calibri,"sans-serif""><strong><span style="background-color:white"><span style="color:black">Conclusion: </span></span></strong><span style="color:black">SCORE2 enhanced the identification of individuals at higher risk of developing CVD and better-discriminated MACE occurrence relatively to SCORE. </span></span></span></p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site